Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of FBXL6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1037.42 | 1445 / 1445 | 100% | 23.36 | 183 / 183 |
ovary | 100% | 726.52 | 180 / 180 | 100% | 28.47 | 430 / 430 |
uterus | 100% | 1051.90 | 170 / 170 | 100% | 21.12 | 459 / 459 |
intestine | 100% | 1626.58 | 966 / 966 | 99% | 38.16 | 524 / 527 |
bladder | 100% | 1059.90 | 21 / 21 | 99% | 28.09 | 498 / 504 |
prostate | 100% | 1271.40 | 245 / 245 | 99% | 13.78 | 496 / 502 |
liver | 100% | 1117.18 | 226 / 226 | 99% | 17.78 | 401 / 406 |
skin | 100% | 1131.20 | 1809 / 1809 | 99% | 17.37 | 466 / 472 |
stomach | 100% | 933.84 | 359 / 359 | 99% | 34.52 | 282 / 286 |
pancreas | 100% | 951.63 | 328 / 328 | 98% | 17.97 | 175 / 178 |
breast | 100% | 1151.30 | 459 / 459 | 98% | 20.27 | 1097 / 1118 |
lung | 100% | 1078.76 | 577 / 578 | 98% | 18.09 | 1131 / 1155 |
adrenal gland | 100% | 1085.57 | 258 / 258 | 96% | 11.41 | 220 / 230 |
brain | 98% | 1154.04 | 2599 / 2642 | 95% | 10.77 | 670 / 705 |
thymus | 100% | 1097.89 | 653 / 653 | 93% | 9.12 | 562 / 605 |
kidney | 100% | 1000.84 | 89 / 89 | 86% | 7.91 | 778 / 901 |
eye | 0% | 0 | 0 / 0 | 100% | 16.99 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.86 | 29 / 29 |
spleen | 100% | 1862.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 48.98 | 1 / 1 |
adipose | 100% | 994.33 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 752.26 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 480.29 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 708.53 | 892 / 929 | 0% | 0 | 0 / 0 |
muscle | 95% | 439.64 | 761 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031146 | Biological process | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
Gene name | FBXL6 |
Protein name | F-box and leucine-rich repeat protein 6, isoform CRA_d (PP14630) F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A) |
Synonyms | hCG_24016 FBL6 |
Description | FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. . |
Accessions | ENST00000455319.6 [Q8N531-2] Q71RB6 ENST00000644788.2 [Q8N531-1] Q8N531 ENST00000331890.6 [Q8N531-1] ENST00000646393.1 [Q8N531-2] |